trimetazidine has been researched along with gentiopicroside in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ji, N; Sheng, Y; Wang, Y; Zhang, H | 1 |
1 other study(ies) available for trimetazidine and gentiopicroside
Article | Year |
---|---|
Gentiopicroside enhances the protective effect of trimetazidine against myocardial ischemia-reperfusion injury via the AMPK/NLRP3 inflammasome signaling.
Topics: AMP-Activated Protein Kinases; Animals; Inflammasomes; Inflammation; Myocardial Reperfusion Injury; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Trimetazidine | 2023 |